CME/CE

Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients

9:15

Faculty: Saad Z. Usmani, MD, MBA Faculty: Natalie S. Callander, MD

This online educational activity reviews the clinical evidence supporting anti-CD38 monoclonal antibody–based combinations as foundational frontline therapy for patients with newly diagnosed multiple myeloma. Faculty examine pivotal clinical trial data and current NCCN Guidelines across transplant-eligible and…